Antengene Receives IND Approval for ATG-201 (CD19 × CD3 TCE) in Autoimmune Disease in China
SHANGHAI and HONG KONG, June 10, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune diseases, solid tumors and hematological malignancies indications, today announced that China's National Medical Products Administration (NMPA) has...
Lynk Pharmaceuticals’ Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 10, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a significant clinical milestone achieved by its global partner, Formation Bio. Formation Bio announced the dosing of the first participant in a Phase 1, first-in-human clinical trial (BLKR201-101-HV)...
PromptBio Launched All-New Agentic AI Platform For Life Sciences, Turning Scientific Intent Into Executable Experiments
The PromptBio Platform combines conversational AI with multi-agent orchestration to accelerate discovery from hypotheses to insights PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- PromptBio, a California-based leader in AI for life sciences, announced the launch of the All-New PromptBio Platform, an Agentic AI designed to help scientists accelerate discovery from hypotheses to insights.  PromptBio: The Agentic AI...
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
COPD study initiation expands HBM9378/WIN378 (also known as SKB378) development into a second major respiratory disease HBM9378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 HBM9378/WIN378 has the potential to be the first-to-market, ultra long-acting anti-TSLP antibody...
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
COPD study initiation expands SKB378/WIN378 development into a second major respiratory disease SKB378/WIN378 is currently being evaluated in the Phase 2/3 POLARIS asthma study, with initial Phase 2 data expected in the second half of 2026 SKB378/WIN378 has the potential to be the first-to-market, ultra long-acting anti-TSLP antibody for asthma...
Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sample preparation time by >90%. Industry-leading Coin Cell DSC temperature range from –80 °C to 600 °C, aiding battery development and QA/QC. MILFORD, Mass., June 9, 2026 /PRNewswire/ -- Waters Corporation (NYSE:...
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
SK bioscience licenses vaccine technology from the U.S. Centers for Disease Control and Prevention SK bioscience is jointly investing with the RIGHT Foundation to drive process development that enhances both efficacy and productivity "We are committed to improving public health through continuous innovation and global partnership." INCHEON, South Korea,...
Duke-NUS awarded €2 million EU grant to help Asia detect outbreaks earlier through wastewater surveillance
EU-funded project will help countries build early-warning systems to spot infectious disease threats before clinical cases surge SINGAPORE, June 9, 2026 /PRNewswire/ -- Duke-NUS Medical School has secured a €2 million EU grant to help countries across Asia strengthen their ability to detect infectious disease threats early, using wastewater and environmental surveillance as a population-level early warning...
Renowned Urologist Dr. (Col) Rajeev Sood joins Manipal Hospital Gurugram to strengthen Comprehensive Urology and Kidney Transplant services
GURUGRAM, India, June 9, 2026 /PRNewswire/ -- Manipal Hospital Gurugram, one of India's leading multi-specialty healthcare institutions, has further strengthened its Department of Urology, Robotics & Renal Transplant with the onboarding of Dr. (Col) Rajeev Sood, Chairman – Urology, Robotics & Renal Transplant. Dr. (Col) Rajeev Sood, Chairman...
Strong Indonesian Demand Reinforces Malaysia Healthcare’s Growth at Malaysia Fair 2026
JAKARTA, Indonesia, June 9, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC), together with Tourism Malaysia, recorded strong visitor engagement at Malaysia Fair Jakarta 2026, held from 4 to 7 June 2026 at Gandaria City, underscoring sustained interest among Indonesian consumers in Malaysia's healthcare, wellness and travel offerings. Organised in conjunction with...
